Coordination

Prof. Thomas Thum, MD, PhD

Director of the IMTTS, MHH

Project Leader, experienced scientist and entrepreneur. Founder of MHH-spin-off company Cardior Pharmaceuticals GmbH (acquired by Novo Nordisk, 2024). Expert in drug development, regulatory needs and setup/ performance of early clinical trials.

Email: Thum.Thomas@mh-hannover.de

Dr. Anne Bührke

Postdoc/ Project Manager at IMTTS, MHH

Certified Project Manager and Biomedical scientist with 4 years experience in project management of preclinical drug development.

Email: Buehrke.Anne@mh-hannover.de